Novel Biomarkers for Thrombosis Risk Prediction in Non–Small-Cell Lung Cancer: Insights from Recent Evidence
Venous thromboembolism (VTE) represents a significant cause of morbidity and mortality in patients with cancer,...
LATEST ARTICLES
The Evolving Landscape of Cerebral Venous Sinus Thrombosis: Emerging Risk Factors and Treatments
Cerebral venous sinus thrombosis (CVST) is a rare yet serious condition, representing an uncommon manifestation of...
Bleeding risk scores in cancer patients: new AI and ML tools
The integration of artificial intelligence (AI) into clinical research has transformed how medical data is analyzed,...
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
The Combined Impact of Serum Albumin and Genetic Risk on VTE: Implications for Early Prevention
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most...
Heparin-Induced Thrombocytopenia: The Expanding Role of Factor Xa Inhibitors in Therapy
Heparin products, such as unfractionated heparin and low-molecular-weight heparin (LMWH), are commonly employed as...